6:02 AM ET
10-Q
Financial Results
Synlogic Q3 2026 Results: Net Loss of $3.87M, Loss Widens
Synlogic, Inc. reported a net loss of $3.9 million for the third quarter of 2026, compared to $2.3 million in the prior year, primarily driven by restructuring and transaction-related charges. The company has discontinued its clinical trials and entered into a merger agreement with Caldera Therapeutics, Inc. as part of a strategic review process. As of September 30, 2026, the company held $11.6 million in cash and cash equivalents.
- Key figure
- Net loss $3.87M